258 related articles for article (PubMed ID: 20627217)
21. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
[TBL] [Abstract][Full Text] [Related]
22. B-type natriuretic peptides for the diagnosis of congestive heart failure in dyspneic oldest-old patients.
Chenevier-Gobeaux C; Delerme S; Allo JC; Arthaud M; Claessens YE; Ekindjian OG; Riou B; Ray P
Clin Biochem; 2008 Sep; 41(13):1049-54. PubMed ID: 18573245
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of emergency Doppler echocardiography for identification of acute left ventricular heart failure in patients with acute dyspnea: comparison with Boston criteria and N-terminal prohormone brain natriuretic peptide.
Nazerian P; Vanni S; Zanobetti M; Polidori G; Pepe G; Federico R; Cangioli E; Grifoni S
Acad Emerg Med; 2010 Jan; 17(1):18-26. PubMed ID: 20078435
[TBL] [Abstract][Full Text] [Related]
24. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.
Mueller C; Scholer A; Laule-Kilian K; Martina B; Schindler C; Buser P; Pfisterer M; Perruchoud AP
N Engl J Med; 2004 Feb; 350(7):647-54. PubMed ID: 14960741
[TBL] [Abstract][Full Text] [Related]
25. Improving the diagnosis of acute heart failure using a validated prediction model.
Steinhart B; Thorpe KE; Bayoumi AM; Moe G; Januzzi JL; Mazer CD
J Am Coll Cardiol; 2009 Oct; 54(16):1515-21. PubMed ID: 19815122
[TBL] [Abstract][Full Text] [Related]
26. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
[TBL] [Abstract][Full Text] [Related]
27. Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.
Knudsen CW; Clopton P; Westheim A; Klemsdal TO; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel AS; Omland T
Ann Emerg Med; 2005 Jun; 45(6):573-80. PubMed ID: 15940086
[TBL] [Abstract][Full Text] [Related]
28. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C
J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053
[TBL] [Abstract][Full Text] [Related]
29. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
[TBL] [Abstract][Full Text] [Related]
30. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
[TBL] [Abstract][Full Text] [Related]
31. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
[TBL] [Abstract][Full Text] [Related]
32. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
[TBL] [Abstract][Full Text] [Related]
33. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study.
Knudsen CW; Omland T; Clopton P; Westheim A; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
J Am Coll Cardiol; 2005 Sep; 46(5):838-44. PubMed ID: 16139134
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic changes as a diagnostic tool in acute heart failure--a pilot study.
Engineer RS; Benoit JL; Hicks CW; Kolattukudy SJ; Burkhoff D; Peacock WF
Am J Emerg Med; 2012 Jan; 30(1):174-80. PubMed ID: 21030189
[TBL] [Abstract][Full Text] [Related]
35. Correlation between impedance cardiography and B-type natriuretic peptide levels in dyspneic patients.
Havelka EG; Rzechula KH; Bryant TO; Anneken SM; Kulstad EB
J Emerg Med; 2011 Feb; 40(2):146-50. PubMed ID: 18790589
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.
Siebert U; Januzzi JL; Beinfeld MT; Cameron R; Gazelle GS
Am J Cardiol; 2006 Sep; 98(6):800-5. PubMed ID: 16950189
[TBL] [Abstract][Full Text] [Related]
37. Bioelectrical impedance analysis for heart failure diagnosis in the ED.
Génot N; Mewton N; Bresson D; Zouaghi O; Francois L; Delwarde B; Kirkorian G; Bonnefoy-Cudraz E
Am J Emerg Med; 2015 Aug; 33(8):1025-9. PubMed ID: 25959843
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
[TBL] [Abstract][Full Text] [Related]
39. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
[TBL] [Abstract][Full Text] [Related]
40. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
